These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2650134)

  • 1. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
    McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts.
    McWhinnie DL; Fuggle SV; Azevedo LS; Jones RM; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3628-9. PubMed ID: 3313873
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of renal allograft rejection with fine needle aspiration biopsy and serum C-reactive protein determinations.
    Kaden J; Strobelt V; Oesterwitz H; Groth J; May G; Eichler C
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1657. PubMed ID: 3274398
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of fine needle aspiration biopsies from renal transplants using monoclonal antibodies as lymphocyte markers.
    Waugh J; Bishop A; Hall BM; Philips J; Duggin G; Tiller D; Sheil A; Horvath J
    Transplant Proc; 1986 Apr; 18(2):267-9. PubMed ID: 3515663
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
    Quiroga I; Salio M; Koo DD; Cerundolo L; Shepherd D; Cerundolo V; Fuggle SV
    Transplantation; 2006 Apr; 81(8):1196-203. PubMed ID: 16641608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.
    von Willebrand E; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal target structures in acute allograft rejection.
    Leszczynski D; Laszczynska M; Halttunen J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of major histocompatibility complex (MHC) class II antigens and HLA-DR incompatibility.
    Oba S; Toma H; Takahashi K; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):323-4. PubMed ID: 2650137
    [No Abstract]   [Full Text] [Related]  

  • 10. Class II major histocompatibility complex antigens on cardiac endothelium: an early biopsy marker of rejection in the transplanted human heart.
    Caforio AL; Bottazzo GF; McKenna WJ; Counihan PJ; Burke M; Poloniecki J; Davies MJ; Pepper JR
    Transplant Proc; 1990 Aug; 22(4):1830-3. PubMed ID: 2202130
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
    [No Abstract]   [Full Text] [Related]  

  • 12. Class II antigens and interleukin 2 expression in renal allograft recipients.
    Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms in organ allograft rejection. An experimental and clinical study.
    Claesson K
    Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class I and class II major histocompatibility complex (MHC) antigens in rejecting human heart grafts.
    Ippoliti G; Lazzaro A; Goggi C; Malavasi F; Di Franco L; Martinelli L; Ascari E; Vigano' M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):445-6. PubMed ID: 2650172
    [No Abstract]   [Full Text] [Related]  

  • 15. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of class II antigen: marker for rejection?
    O'Brien J; Horsburgh T; Veitch PS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):211-2. PubMed ID: 3152689
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
    Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation antigens on renal endothelium.
    Paul LC; Baldwin WM; Van Es LA
    Neth J Med; 1982; 25(7):208-14. PubMed ID: 6755279
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
    Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
    Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes.
    Russ GR; Pascoe V; d'Apice AJ; Seymour AE
    Transplant Proc; 1986 Apr; 18(2):293-7. PubMed ID: 3515666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.